Padovani A

Title : Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study - Colombo_2018_J.Womens.Health.(Larchmt)_27_1368

Author(s) : Colombo D , Caltagirone C , Padovani A , Sorbi S , Spalletta G , Simoni L , Ori A , Zagni E

Ref : J Womens Health (Larchmt) , 27 :1368 , 2018

Abstract : Colombo_2018_J.Womens.Health.(Larchmt)_27_1368

ESTHER : Colombo_2018_J.Womens.Health.(Larchmt)_27_1368

PubMedSearch : Colombo_2018_J.Womens.Health.(Larchmt)_27_1368

PubMedID: 30085899

Title : Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study - Boccardi_2016_JAMA.Neurol_73_1417

Author(s) : Boccardi M , Altomare D , Ferrari C , Festari C , Guerra UP , Paghera B , Pizzocaro C , Lussignoli G , Geroldi C , Zanetti O , Cotelli MS , Turla M , Borroni B , Rozzini L , Mirabile D , Defanti C , Gennuso M , Prelle A , Gentile S , Morandi A , Vollaro S , Volta GD , Bianchetti A , Conti MZ , Cappuccio M , Carbone P , Bellandi D , Abruzzi L , Bettoni L , Villani D , Raimondi MC , Lanari A , Ciccone A , Facchi E , Di Fazio I , Rozzini R , Boffelli S , Manzoni L , Salvi GP , Cavaliere S , Belotti G , Avanzi S , Pasqualetti P , Muscio C , Padovani A , Frisoni GB

Ref : JAMA Neurol , 73 :1417 , 2016

Abstract : Boccardi_2016_JAMA.Neurol_73_1417

ESTHER : Boccardi_2016_JAMA.Neurol_73_1417

PubMedSearch : Boccardi_2016_JAMA.Neurol_73_1417

PubMedID: 27802513

Title : Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study - Spalletta_2014_PLoS.One_9_e89216

Author(s) : Spalletta G , Caltagirone C , Padovani A , Sorbi S , Attar M , Colombo D , Cravello L

Ref : PLoS ONE , 9 :e89216 , 2014

Abstract : Spalletta_2014_PLoS.One_9_e89216

ESTHER : Spalletta_2014_PLoS.One_9_e89216

PubMedSearch : Spalletta_2014_PLoS.One_9_e89216

PubMedID: 24586603

Title : [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis - Marcone_2012_J.Alzheimers.Dis_31_387

Author(s) : Marcone A , Garibotto V , Moresco RM , Florea I , Panzacchi A , Carpinelli A , Virta JR , Tettamanti M , Borroni B , Padovani A , Bertoldo A , Herholz K , Rinne JO , Cappa SF , Perani D

Ref : J Alzheimers Dis , 31 :387 , 2012

Abstract : Marcone_2012_J.Alzheimers.Dis_31_387

ESTHER : Marcone_2012_J.Alzheimers.Dis_31_387

PubMedSearch : Marcone_2012_J.Alzheimers.Dis_31_387

PubMedID: 22596267

Title : Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors - Rozzini_2010_Int.Psychogeriatr_22_114

Author(s) : Rozzini L , Chilovi BV , Conti M , Bertoletti E , Zanetti M , Trabucchi M , Padovani A

Ref : Int Psychogeriatr , 22 :114 , 2010

Abstract : Rozzini_2010_Int.Psychogeriatr_22_114

ESTHER : Rozzini_2010_Int.Psychogeriatr_22_114

PubMedSearch : Rozzini_2010_Int.Psychogeriatr_22_114

PubMedID: 19552831

Title : Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling - Borroni_2009_Cogn.Behav.Neurol_22_222

Author(s) : Borroni B , Grassi M , Costanzi C , Bianchi M , Padovani A

Ref : Cogn Behav Neurol , 22 :222 , 2009

Abstract : Borroni_2009_Cogn.Behav.Neurol_22_222

ESTHER : Borroni_2009_Cogn.Behav.Neurol_22_222

PubMedSearch : Borroni_2009_Cogn.Behav.Neurol_22_222

PubMedID: 19996874

Title : Serum albumin level interferes with the effect of Donepezil in Alzheimer's disease - Rozzini_2008_Aging.Clin.Exp.Res_20_509

Author(s) : Rozzini L , Vicini Chilovi B , Bertoletti E , Ghianda D , Conti M , Trabucchi M , Padovani A

Ref : Aging Clin Exp Res , 20 :509 , 2008

Abstract : Rozzini_2008_Aging.Clin.Exp.Res_20_509

ESTHER : Rozzini_2008_Aging.Clin.Exp.Res_20_509

PubMedSearch : Rozzini_2008_Aging.Clin.Exp.Res_20_509

PubMedID: 19179833

Title : Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study - Rozzini_2007_Am.J.Alzheimers.Dis.Other.Demen_22_42

Author(s) : Rozzini L , Chilovi BV , Bertoletti E , Conti M , Delrio I , Trabucchi M , Padovani A

Ref : Am J Alzheimers Dis Other Demen , 22 :42 , 2007

Abstract : Rozzini_2007_Am.J.Alzheimers.Dis.Other.Demen_22_42

ESTHER : Rozzini_2007_Am.J.Alzheimers.Dis.Other.Demen_22_42

PubMedSearch : Rozzini_2007_Am.J.Alzheimers.Dis.Other.Demen_22_42

PubMedID: 17534001

Title : Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors - Rozzini_2007_Int.J.Geriatr.Psychiatry_22_356

Author(s) : Rozzini L , Costardi D , Chilovi BV , Franzoni S , Trabucchi M , Padovani A

Ref : Int J Geriatr Psychiatry , 22 :356 , 2007

Abstract : Rozzini_2007_Int.J.Geriatr.Psychiatry_22_356

ESTHER : Rozzini_2007_Int.J.Geriatr.Psychiatry_22_356

PubMedSearch : Rozzini_2007_Int.J.Geriatr.Psychiatry_22_356

PubMedID: 17117398

Title : Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease - Rozzini_2007_Aging.Clin.Exp.Res_19_220

Author(s) : Rozzini L , Vicini Chilovi B , Bertoletti E , Trabucchi M , Padovani A

Ref : Aging Clin Exp Res , 19 :220 , 2007

Abstract : Rozzini_2007_Aging.Clin.Exp.Res_19_220

ESTHER : Rozzini_2007_Aging.Clin.Exp.Res_19_220

PubMedSearch : Rozzini_2007_Aging.Clin.Exp.Res_19_220

PubMedID: 17607090

Title : Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients - Borroni_2005_J.Neurol.Sci_229-230_211

Author(s) : Borroni B , Agosti C , Martini G , Volpi R , Brambilla C , Caimi L , Di Luca M , Padovani A

Ref : Journal of Neurology Sci , 229-230 :211 , 2005

Abstract : Borroni_2005_J.Neurol.Sci_229-230_211

ESTHER : Borroni_2005_J.Neurol.Sci_229-230_211

PubMedSearch : Borroni_2005_J.Neurol.Sci_229-230_211

PubMedID: 15760641

Title : Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics - Caltagirone_2005_Drugs.Aging_22 Suppl 1_1

Author(s) : Caltagirone C , Bianchetti A , Di Luca M , Mecocci P , Padovani A , Pirfo E , Scapicchio P , Senin U , Trabucchi M , Musicco M

Ref : Drugs & Aging , 22 Suppl 1 :1 , 2005

Abstract : Caltagirone_2005_Drugs.Aging_22 Suppl 1_1

ESTHER : Caltagirone_2005_Drugs.Aging_22 Suppl 1_1

PubMedSearch : Caltagirone_2005_Drugs.Aging_22 Suppl 1_1

PubMedID: 16506439

Title : Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients - Zimmermann_2005_Neurobiol.Dis_19_237

Author(s) : Zimmermann M , Borroni B , Cattabeni F , Padovani A , Di Luca M

Ref : Neurobiol Dis , 19 :237 , 2005

Abstract : Zimmermann_2005_Neurobiol.Dis_19_237

ESTHER : Zimmermann_2005_Neurobiol.Dis_19_237

PubMedSearch : Zimmermann_2005_Neurobiol.Dis_19_237

PubMedID: 15837579

Title : Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the real world (CRONOS project): a 36-week follow-up study - Bellelli_2005_Aging.Clin.Exp.Res_17_54

Author(s) : Bellelli G , Lucchi E , Minicuci N , Rozzini L , Bianchetti A , Padovani A , Trabucchi M

Ref : Aging Clin Exp Res , 17 :54 , 2005

Abstract : Bellelli_2005_Aging.Clin.Exp.Res_17_54

ESTHER : Bellelli_2005_Aging.Clin.Exp.Res_17_54

PubMedSearch : Bellelli_2005_Aging.Clin.Exp.Res_17_54

PubMedID: 15847123

Title : Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy - Rozzini_2005_Int.J.Geriatr.Psychiatry_20_547

Author(s) : Rozzini L , Vicini Chilovi B , Bellelli G , Bertoletti E , Trabucchi M , Padovani A

Ref : Int J Geriatr Psychiatry , 20 :547 , 2005

Abstract : Rozzini_2005_Int.J.Geriatr.Psychiatry_20_547

ESTHER : Rozzini_2005_Int.J.Geriatr.Psychiatry_20_547

PubMedSearch : Rozzini_2005_Int.J.Geriatr.Psychiatry_20_547

PubMedID: 15920713

Title : Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines - Zimmermann_2004_J.Neurochem_90_1489

Author(s) : Zimmermann M , Gardoni F , Marcello E , Colciaghi F , Borroni B , Padovani A , Cattabeni F , Di Luca M

Ref : Journal of Neurochemistry , 90 :1489 , 2004

Abstract : Zimmermann_2004_J.Neurochem_90_1489

ESTHER : Zimmermann_2004_J.Neurochem_90_1489

PubMedSearch : Zimmermann_2004_J.Neurochem_90_1489

PubMedID: 15341532

Title : Predicting cognitive decline in Alzheimer disease. Role of platelet amyloid precursor protein - Borroni_2004_Alzheimer.Dis.Assoc.Disord_18_32

Author(s) : Borroni B , Colciaghi F , Archetti S , Marcello E , Caimi L , Di Luca M , Padovani A

Ref : Alzheimer Disease & Associated Disorders , 18 :32 , 2004

Abstract : Borroni_2004_Alzheimer.Dis.Assoc.Disord_18_32

ESTHER : Borroni_2004_Alzheimer.Dis.Assoc.Disord_18_32

PubMedSearch : Borroni_2004_Alzheimer.Dis.Assoc.Disord_18_32

PubMedID: 15195460

Title : Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease - Borroni_2003_Neurosci.Lett_343_213

Author(s) : Borroni B , Pettenati C , Bordonali T , Akkawi N , Di Luca M , Padovani A

Ref : Neuroscience Letters , 343 :213 , 2003

Abstract : Borroni_2003_Neurosci.Lett_343_213

ESTHER : Borroni_2003_Neurosci.Lett_343_213

PubMedSearch : Borroni_2003_Neurosci.Lett_343_213

PubMedID: 12770699

Title : ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model - Borroni_2002_Eur.Neuropsychopharmacol_12_195

Author(s) : Borroni B , Colciaghi F , Pastorino L , Archetti S , Corsini P , Cattabeni F , Di Luca M , Padovani A

Ref : European Neuropsychopharmacology , 12 :195 , 2002

Abstract : Borroni_2002_Eur.Neuropsychopharmacol_12_195

ESTHER : Borroni_2002_Eur.Neuropsychopharmacol_12_195

PubMedSearch : Borroni_2002_Eur.Neuropsychopharmacol_12_195

PubMedID: 12007670

Title : Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target - Padovani_2001_Mech.Ageing.Dev_122_1997

Author(s) : Padovani A , Borroni B , Colciaghi F , Pastorino L , Archetti S , Cottini E , Caimi L , Cattabeni F , Di Luca M

Ref : Mech Ageing Dev , 122 :1997 , 2001

Abstract : Padovani_2001_Mech.Ageing.Dev_122_1997

ESTHER : Padovani_2001_Mech.Ageing.Dev_122_1997

PubMedSearch : Padovani_2001_Mech.Ageing.Dev_122_1997

PubMedID: 11589917

Title : Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment - Borroni_2001_Arch.Neurol_58_442

Author(s) : Borroni B , Colciaghi F , Pastorino L , Pettenati C , Cottini E , Rozzini L , Monastero R , Lenzi GL , Cattabeni F , Di Luca M , Padovani A

Ref : Archives of Neurology , 58 :442 , 2001

Abstract : Borroni_2001_Arch.Neurol_58_442

ESTHER : Borroni_2001_Arch.Neurol_58_442

PubMedSearch : Borroni_2001_Arch.Neurol_58_442

PubMedID: 11255448

Padovani A

General

References (21)

Padovani A

General

References (21)

1. Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study

2. Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

3. Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study

4. [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis

5. Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

6. Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling

7. Serum albumin level interferes with the effect of Donepezil in Alzheimer's disease

8. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study

9. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors

10. Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease

11. Cholinesterase inhibitors exert a protective effect on endothelial damage in Alzheimer disease patients

12. Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics

13. Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients

14. Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the real world (CRONOS project): a 36-week follow-up study

15. Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy

16. Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines

17. Predicting cognitive decline in Alzheimer disease. Role of platelet amyloid precursor protein

18. Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease

19. ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model

20. Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target

21. Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment